VIP
Vasoactive intestinal peptide, or VIP, is a naturally occurring signalling peptide with roles in the nervous system, digestive tract and immune system. It also contributes to communication within the body's circadian clock.
These physiological functions have made VIP a focus of research into inflammation and sleep. Proposed uses at MRC begin with physician-led assessment.
What Is VIP?
VIP is a 28-amino-acid neuropeptide produced by nerve cells and some immune cells. It influences blood-vessel tone, intestinal secretion and smooth-muscle activity.
Its widespread distribution helps explain why externally administered VIP may affect several organ systems rather than a single symptom.
How Does VIP Work?
VIP primarily activates VPAC1 and VPAC2 receptors, which influence intracellular cyclic AMP signalling. These pathways can alter immune responses, secretion and vascular relaxation.
VIP signalling also helps coordinate cells in the suprachiasmatic nucleus, the brain's central circadian clock. This has made sleep a growing research focus.
What Has Research Studied?
Experimental work examines immune regulation, intestinal inflammation and circadian physiology. Clinical development has explored selected pulmonary and other disease settings using particular formulations.
Evidence varies substantially by condition and route. VIP is not an established general treatment for autoimmune disease, chronic inflammation or circadian disturbance.
Safety and Medical Supervision
Vascular and gastrointestinal effects can include reduced blood pressure, flushing and diarrhoea. Other medicines and existing cardiovascular conditions may affect suitability.
A physician confirms the exact product and indication, provides appropriate oversight, and ensures treatment complements established care.
Frequently Asked Questions
Is VIP a sleep medicine?
Its role in the circadian clock is established physiology, but administered VIP is not an established treatment for insomnia.
Can VIP treat autoimmune disease?
Experimental immune findings inform ongoing clinical research, and treatment decisions draw on evidence for the particular condition.
Can VIP affect blood pressure?
Yes. VIP can dilate blood vessels and reduce blood pressure, which is relevant to cardiovascular assessment and concurrent medicines.
Is a naturally occurring peptide automatically safe?
Administered amounts, route and exposure differ from normal physiological signalling, so dosing and monitoring are physician-led.
References
- PubMed. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1
- PubMed. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions
- PubMed. Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system
Disclaimer
This information, including but not limited to texts, images, graphics, labels, ingredients, indications, potential benefits, and other materials contained on this website are for informational purposes only. No part of this website is intended to be a substitute for professional medical advice, treatment, or diagnosis. Always seek the advice of your physician or other professional healthcare provider, particularly before starting a new regimen for the first time.
Related Peptides
Wondering Whether VIP Is Right for You?
Speak with our medical team about your health goals. We will help you understand which options are supported by evidence and appropriate for your situation.